Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Abstract 4179: Magnetic resonance imaging and bioluminescence imaging for evaluating tumor burden in orthotopic glioblastoma

Mingrui Guo, Ruisong Su, Jeff W H Chor, Zheyan Zhang, Mandy Tan, Xing Qi Teo, Haosheng Feng, Kuan J. Lee, Li Hua, Longyun Zhang, Jie Cai, Guanping Mao, Jingjing Wang, Keefe Chng, Weiping Han, Colin Guo

Cancer Res (2024) 84 (6_Supplement): 4179.

https://doi.org/10.1158/1538-7445.AM2024-4179

Published: 22 March 2024

View article titled, Abstract 4179: Magnetic resonance imaging and bioluminescence imaging for evaluating tumor burden in orthotopic glioblastoma

Journal Articles

Abstract 2788: Characterization of a panel of orthotopic syngeneic models using bioluminescent imaging for the evaluation of immuno oncology therapeutics

Diandong Jiang, Bryan Miller, Yanrui Song, Rajendra Kumari, Annie An, Jie Cai, Davy Xuesong Ouyang, Henry Qixiang Li, Yinfei Yin

Cancer Res (2020) 80 (16_Supplement): 2788.

https://doi.org/10.1158/1538-7445.AM2020-2788

Published: 15 August 2020

View article titled, Abstract 2788: Characterization of a panel of orthotopic syngeneic models using bioluminescent imaging for the evaluation of immuno oncology therapeutics

Journal Articles

Abstract 1060: Establishment of a panel of prostate patient derived xenograft (PDX) models and evaluation of anti-androgen therapy

Jason Davis, Anthony Oakden, Jane Wrigley, Chira Roberts, W Qian, Bin Fan, A Collins, Davy Ouyang, Jie Cai, Rajendra Kumari, Yinfei Yin

Cancer Res (2019) 79 (13_Supplement): 1060.

https://doi.org/10.1158/1538-7445.AM2019-1060

Published: 01 July 2019

View article titled, Abstract 1060: Establishment of a panel of prostate patient derived xenograft (PDX) models and evaluation of anti-androgen therapy

Journal Articles

Abstract 1144: Building Kras (G12D)/Trp53 null/Pdx1-cre (KPC) mouse allograft tumor model for efficacy evaluation of combinatory immunotherapies

Yanrui Song, Benqi Liu, Annie Xiaoyu An, Likun Zhang, Jie Cai, Qian Shi, Henry Qixiang Li, Davy Xuesong Ouyang

Cancer Res (2018) 78 (13_Supplement): 1144.

https://doi.org/10.1158/1538-7445.AM2018-1144

Published: 01 July 2018

View article titled, Abstract 1144: Building Kras (G12D)/Trp53 null/Pdx1-cre (KPC) mouse allograft tumor model for efficacy evaluation of combinatory immunotherapies

Journal Articles

Abstract 5116: Development of murine tumor homograft panels and their genetic fingerprints for their identification to ensure the quality controlled I/O studies using these models

Jie Cai, Wubin Qian, Bin Fan, Xiaobo Chen, Sheng Guo, Davy Ouyang, Wenqing Yang, Annie An, Jinglei Bi, Dongliang Mo, Henry Li

Cancer Res (2018) 78 (13_Supplement): 5116.

https://doi.org/10.1158/1538-7445.AM2018-5116

Published: 01 July 2018

View article titled, Abstract 5116: Development of murine tumor homograft panels and their genetic fingerprints for their identification to ensure the quality controlled I/O studies using these models

Journal Articles

Abstract 2167: Efficacy assessment of BTK inhibitor ibrutinib in de novo and viral-induced B cell lymphoma

Jessie Jingjing Wang, Meiling Zheng, Xuesong Huang, Yanrui Song, Wubin Qian, Likun Zhang, Jie Cai, Sheng Guo, Henry Qixiang Li, Davy Xuesong Ouyang

Cancer Res (2018) 78 (13_Supplement): 2167.

https://doi.org/10.1158/1538-7445.AM2018-2167

Published: 01 July 2018

View article titled, Abstract 2167: Efficacy assessment of BTK inhibitor ibrutinib in de novo and viral-induced B cell lymphoma

Journal Articles

Abstract 2008: Intestinal microbiota may dynamically facilitate the anti-PD-L1 immunotherapy

Jia Xue, Zhun Wang, Sheng Guo, Jie Cai, Davy Ouyang, Bin Cai, Gang Chen, Jie Liu, Xin Dong, Henry Li

Cancer Res (2017) 77 (13_Supplement): 2008.

https://doi.org/10.1158/1538-7445.AM2017-2008

Published: 01 July 2017

View article titled, Abstract 2008: Intestinal microbiota may dynamically facilitate the anti-PD-L1 immunotherapy

Journal Articles

Abstract 396: Detecting copy number variations using WES datasets in patient derived xenografts

Jia Xue, Wubin Qian, Sheng Guo, Jie Cai, Henry Qixiang Li

Cancer Res (2017) 77 (13_Supplement): 396.

https://doi.org/10.1158/1538-7445.AM2017-396

Published: 01 July 2017

View article titled, Abstract 396: Detecting copy number variations using WES datasets in patient derived xenografts

Journal Articles

Abstract 2807: Developing a variety of primary mouse tumor allograft models for evaluating efficacy of PARP inhibitor

Gavin Jiagui Qu, Davy Xuesong Ouyang, Li Chen, Likun Zhang, Annie Xiaoyu An, Jie Cai, Henry Q. X. Li

Cancer Res (2017) 77 (13_Supplement): 2807.

https://doi.org/10.1158/1538-7445.AM2017-2807

Published: 01 July 2017

View article titled, Abstract 2807: Developing a variety of primary mouse tumor allograft models for evaluating efficacy of PARP inhibitor

Journal Articles

Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines

Sheng Guo, Wubin Qian, Jie Cai, Likun Zhang, Jean-Pierre Wery, Qi-Xiang Li

Cancer Res (2016) 76 (16): 4619–4626.

https://doi.org/10.1158/0008-5472.CAN-15-3245

Published: 14 August 2016

View article titled, Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines

Includes: Supplementary data

Journal Articles

Abstract 3219: Prior vaccination is critical to PD1/PDL-1 treatment efficacy in a mouse breast cancer allograft

Zhun Wang, Xiaoyu An, Jinping Liu, Xuesong Ouyang, Jiagui Qu, Likun Zhang, Jie Cai, Jean-Pierre Wery, Henry Li

Cancer Res (2016) 76 (14_Supplement): 3219.

https://doi.org/10.1158/1538-7445.AM2016-3219

Published: 15 July 2016

View article titled, Abstract 3219: Prior vaccination is critical to PD1/PDL-1 treatment efficacy in a mouse breast cancer allograft

Journal Articles

Abstract 747: Paracrine c-MET/HGF HCC PDX: evaluation of a biologics targeting c-MET

Dawei Chen, Ziyong Sun, Likun Zhang, Jie Cai, Davy X. Ouyang, Jean-Pierre Wery, Henry Li

Cancer Res (2016) 76 (14_Supplement): 747.

https://doi.org/10.1158/1538-7445.AM2016-747

Published: 15 July 2016

View article titled, Abstract 747: Paracrine c-MET/HGF HCC PDX: evaluation of a biologics targeting c-MET

Journal Articles

Abstract 4043: Establishment of a mouse skin squamous cell carcinoma allograft model for in vivo pharmacological analysis of immunotherapy

Gavin Jiagui Qu, Annie Xiaoyu An, Jinping Liu, Davy Xuesong Ouyang, Likun Zhang, Jie Cai, Jean Pierre Wery, Henry Q. X. Li.

Cancer Res (2016) 76 (14_Supplement): 4043.

https://doi.org/10.1158/1538-7445.AM2016-4043

Published: 15 July 2016

View article titled, Abstract 4043: Establishment of a mouse skin squamous cell carcinoma allograft model for in vivo pharmacological analysis of immunotherapy

Journal Articles

Abstract 3581: Rapid conversion to resistance, of a colon PDX with ret-fusion, by ponatinib treatment could potentially be attributed to the introduction of the gate keeper mutation V804M

Mengmeng Yang, Jie Cai, Sheng Guo, Jean-Pierre Wery, Henry Qixiang Li

Cancer Res (2015) 75 (15_Supplement): 3581.

https://doi.org/10.1158/1538-7445.AM2015-3581

Published: 01 August 2015

View article titled, Abstract 3581: Rapid conversion to resistance, of a colon PDX with ret-fusion, by ponatinib treatment could potentially be attributed to the introduction of the gate keeper mutation V804M

Journal Articles

Abstract 1926: Patient-derived xenografts seem to have closer global expression profile to that of the patient tumors of the corresponding cancer types, than the equivalent cell lines do

Sheng Guo, Wubin Qian, Jie Cai, Jean-Pierre Wery, Henry Qixiang Li

Cancer Res (2015) 75 (15_Supplement): 1926.

https://doi.org/10.1158/1538-7445.AM2015-1926

Published: 01 August 2015

View article titled, Abstract 1926: Patient-derived xenografts seem to have closer global expression profile to that of the patient tumors of the corresponding cancer types, than the equivalent cell lines do

Journal Articles

Abstract 2281: Building mouse tumor derived allogragfts for immune-oncology research

Xiaoyu An, Jinping Liu, Jie Cai, Jean-Pierre Wery, Henry Qixiang Li

Cancer Res (2015) 75 (15_Supplement): 2281.

https://doi.org/10.1158/1538-7445.AM2015-2281

Published: 01 August 2015

View article titled, Abstract 2281: Building mouse tumor derived allogragfts for immune-oncology research

Journal Articles

Abstract 1472: Building comprehensive and fully annotated patient tumor derived xenogragft (PDX) library mirroring cancer patient population

Jie Cai, Dawei Chen, Rajendra Kumari, Sheng Guo, Jie Yang, Mengmeng Yang, Andrew McKenzie, Zhun Wang, Xuesong Huang, Xiaoyu An, Jinping Liu, Jean-Pierre Wery, Henry Li

Cancer Res (2015) 75 (15_Supplement): 1472.

https://doi.org/10.1158/1538-7445.AM2015-1472

Published: 01 August 2015

View article titled, Abstract 1472: Building comprehensive and fully annotated patient tumor derived xenogragft (PDX) library mirroring cancer patient population

Journal Articles

Abstract 769: In vivo response and molecular characterization of a Caucasian NSCLC squamous cell carcinoma PDX sensitive to FGFR inhibitors

Andrew McKenzie, Nektaria Papadopoulou, Yinfei Yin, Simon Jiang, Jane Wrigley, Jie Cai, Martin Page, Henry Li, Rajendra Kumari

Cancer Res (2015) 75 (15_Supplement): 769.

https://doi.org/10.1158/1538-7445.AM2015-769

Published: 01 August 2015

View article titled, Abstract 769: In vivo response and molecular characterization of a Caucasian NSCLC squamous cell carcinoma PDX sensitive to FGFR inhibitors

Journal Articles

Abstract 3123: Modeling anti-leukemic therapy by patient derived AML xenografts with distinct phenotypes/geneotypes

Jinping Liu, Xiaoyu An, Na Wang, Di Wang, Liang Huang, Ran Wu, Jie Cai, Jean-Pierre Wery, Henry Li

Cancer Res (2014) 74 (19_Supplement): 3123.

https://doi.org/10.1158/1538-7445.AM2014-3123

Published: 01 October 2014

View article titled, Abstract 3123: Modeling anti-leukemic therapy by patient derived AML xenografts with distinct phenotypes/geneotypes

Journal Articles

Abstract 337: A NSCLC PDX with EML4-ALK fusion mutation responds to crizotinib.

Jie Cai, Mengmeng Yang, Jianyun Deng, Xiaoming Song, Xuesong Huang, Taiping Chen, Jean Pierre Wery, Yiyou Chen, Henry QX Li

Cancer Res (2013) 73 (8_Supplement): 337.

https://doi.org/10.1158/1538-7445.AM2013-337

Published: 15 April 2013

View article titled, Abstract 337: A NSCLC PDX with EML4-ALK fusion mutation responds to crizotinib.

NARROW

Abstract 4179: Magnetic resonance imaging and bioluminescence imaging for evaluating tumor burden in orthotopic glioblastoma

Abstract 2788: Characterization of a panel of orthotopic syngeneic models using bioluminescent imaging for the evaluation of immuno oncology therapeutics

Abstract 1060: Establishment of a panel of prostate patient derived xenograft (PDX) models and evaluation of anti-androgen therapy

Abstract 1144: Building Kras (G12D)/Trp53 null/Pdx1-cre (KPC) mouse allograft tumor model for efficacy evaluation of combinatory immunotherapies

Abstract 5116: Development of murine tumor homograft panels and their genetic fingerprints for their identification to ensure the quality controlled I/O studies using these models

Abstract 2167: Efficacy assessment of BTK inhibitor ibrutinib in de novo and viral-induced B cell lymphoma

Abstract 2008: Intestinal microbiota may dynamically facilitate the anti-PD-L1 immunotherapy

Abstract 396: Detecting copy number variations using WES datasets in patient derived xenografts

Abstract 2807: Developing a variety of primary mouse tumor allograft models for evaluating efficacy of PARP inhibitor

Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines

Abstract 3219: Prior vaccination is critical to PD1/PDL-1 treatment efficacy in a mouse breast cancer allograft

Abstract 747: Paracrine c-MET/HGF HCC PDX: evaluation of a biologics targeting c-MET

Abstract 4043: Establishment of a mouse skin squamous cell carcinoma allograft model for in vivo pharmacological analysis of immunotherapy

Abstract 3581: Rapid conversion to resistance, of a colon PDX with ret-fusion, by ponatinib treatment could potentially be attributed to the introduction of the gate keeper mutation V804M

Abstract 1926: Patient-derived xenografts seem to have closer global expression profile to that of the patient tumors of the corresponding cancer types, than the equivalent cell lines do

Abstract 2281: Building mouse tumor derived allogragfts for immune-oncology research

Abstract 1472: Building comprehensive and fully annotated patient tumor derived xenogragft (PDX) library mirroring cancer patient population

Abstract 769: In vivo response and molecular characterization of a Caucasian NSCLC squamous cell carcinoma PDX sensitive to FGFR inhibitors

Abstract 3123: Modeling anti-leukemic therapy by patient derived AML xenografts with distinct phenotypes/geneotypes

Abstract 337: A NSCLC PDX with EML4-ALK fusion mutation responds to crizotinib.

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only